| Benchmark | N | Rowan FEP/TMD (2ns, AM1-BCC) | Rowan FEP/TMD (4ns, Mango/RESP) | FEP+ (20ns) | OpenFE (5ns) | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMSE | MAE | R2 | Ο | min/lig | RMSE | MAE | R2 | Ο | min/lig | RMSE | MAE | R2 | Ο | RMSE | MAE | R2 | Ο | ||
| JACS | |||||||||||||||||||
| TYK2 | 16 | 0.47 | 0.37 | 0.87 | 0.91 | 8.9 | 0.34 | 0.29 | 0.93 | 0.94 | 13.8 | 0.47 | 0.37 | 0.86 | 0.92 | 0.59 | 0.48 | 0.80 | 0.87 |
| BACE | 36 | 1.52 | 1.14 | 0.26 | 0.53 | 9.3 | 1.04 | 0.91 | 0.56 | 0.68 | 13.3 | 0.75 | 0.58 | 0.39 | 0.55 | 0.96 | 0.74 | 0.30 | 0.64 |
| CDK2 | 16 | 1.10 | 0.81 | 0.44 | 0.69 | 11.5 | 1.03 | 0.84 | 0.49 | 0.66 | 16.2 | 0.90 | 0.72 | 0.42 | 0.63 | 0.84 | 0.70 | 0.60 | 0.82 |
| JNK1 | 21 | 1.55 | 1.32 | 0.19 | 0.52 | 20.6 | 1.54 | 1.39 | 0.56 | 0.76 | 29.2 | 0.57 | 0.46 | 0.71 | 0.87 | 0.85 | 0.72 | 0.58 | 0.77 |
| MCL1 | 42 | 1.33 | 0.97 | 0.52 | 0.76 | 12.2 | 1.25 | 0.91 | 0.64 | 0.81 | 14.4 | 0.86 | 0.69 | 0.49 | 0.67 | 1.17 | 0.91 | 0.49 | 0.71 |
| p38 | 34 | 1.11 | 0.88 | 0.47 | 0.68 | 15.0 | 0.97 | 0.85 | 0.53 | 0.69 | 19.3 | 0.81 | 0.63 | 0.49 | 0.72 | 1.25 | 0.93 | 0.18 | 0.44 |
| PTP1B | 23 | 0.92 | 0.66 | 0.49 | 0.63 | 21.9 | 0.96 | 0.71 | 0.44 | 0.57 | 22.8 | 0.51 | 0.41 | 0.85 | 0.87 | 0.88 | 0.71 | 0.61 | 0.75 |
| Thrombin | 11 | 0.54 | 0.42 | 0.50 | 0.62 | 18.8 | 0.98 | 0.77 | 0.53 | 0.77 | 18.9 | 0.53 | 0.42 | 0.68 | 0.78 | 0.52 | 0.39 | 0.57 | 0.61 |
| Average | 1.07 | 0.82 | 0.47 | 0.67 | 14.8 | 1.01 | 0.83 | 0.58 | 0.74 | 18.5 | 0.68 | 0.53 | 0.61 | 0.75 | 0.88 | 0.70 | 0.52 | 0.70 | |
| Merck | |||||||||||||||||||
| CDK8 | 32 | 2.08 | 1.70 | 0.73 | 0.87 | 50.5 | β | β | β | β | β | 1.13 | 0.93 | 0.56 | 0.76 | 1.20 | 0.99 | 0.63 | 0.76 |
| cMet (Neutral) | 12 | 1.39 | 1.11 | 0.77 | 0.75 | 17.7 | β | β | β | β | β | 0.83 | 0.74 | 0.73 | 0.83 | 1.11 | 0.91 | 0.73 | 0.74 |
| cMet (Positive) | 12 | 1.38 | 1.15 | 0.66 | 0.83 | 28.3 | β | β | β | β | β | 0.62 | 0.51 | 0.78 | 0.93 | 1.56 | 1.25 | 0.06 | 0.26 |
| Eg5 (Neutral) | 9 | 1.09 | 0.97 | 0.62 | 0.67 | 19.0 | β | β | β | β | β | 0.64 | 0.55 | 0.54 | 0.78 | 1.01 | 0.84 | 0.59 | 0.65 |
| Eg5 (Positive) | 19 | 1.64 | 1.47 | 0.03 | 0.22 | 30.2 | β | β | β | β | β | 0.94 | 0.68 | 0.23 | 0.47 | 0.93 | 0.79 | 0.05 | 0.23 |
| HIF2a | 41 | 1.89 | 1.55 | 0.06 | 0.22 | 8.2 | β | β | β | β | β | 0.77 | 0.66 | 0.61 | 0.66 | 1.59 | 1.35 | 0.40 | 0.57 |
| PFKFB3 | 40 | 1.17 | 0.93 | 0.30 | 0.54 | 11.8 | β | β | β | β | β | 0.99 | 0.77 | 0.58 | 0.76 | 1.11 | 0.90 | 0.41 | 0.63 |
| SHP2 | 26 | 2.54 | 1.90 | 0.28 | 0.49 | 16.8 | β | β | β | β | β | 1.11 | 0.92 | 0.50 | 0.74 | 2.06 | 1.75 | 0.00 | 0.13 |
| SYK (Negative) | 6 | 2.37 | 1.90 | 0.55 | -0.94 | 60.4 | β | β | β | β | β | 0.84 | 0.66 | 0.60 | -0.94 | 2.40 | 1.68 | 0.81 | -0.94 |
| SYK (Neutral) | 38 | 1.05 | 0.88 | 0.11 | 0.16 | 12.4 | β | β | β | β | β | 0.75 | 0.58 | 0.45 | 0.58 | 1.03 | 0.77 | 0.38 | 0.43 |
| TNKS2 (Neutral) | 21 | 0.77 | 0.59 | 0.41 | 0.62 | 8.2 | β | β | β | β | β | 0.69 | 0.58 | 0.63 | 0.63 | 0.78 | 0.60 | 0.46 | 0.56 |
| TNKS2 (Positive) | 6 | 0.89 | 0.80 | 0.10 | 0.26 | 8.9 | β | β | β | β | β | 0.85 | 0.70 | 0.48 | 0.66 | 0.53 | 0.44 | 0.84 | 0.83 |
| Average | 1.52 | 1.25 | 0.38 | 0.39 | 22.7 | β | β | β | β | β | 0.85 | 0.69 | 0.56 | 0.57 | 1.28 | 1.02 | 0.45 | 0.40 | |
| Waterset | |||||||||||||||||||
| BRD4 | 8 | 2.24 | 1.83 | 0.25 | -0.10 | 6.2 | β | β | β | β | β | 0.98 | 0.83 | 0.00 | 0.05 | 0.65 | 0.59 | 0.43 | 0.81 |
| HSP90 (Kung) | 11 | 1.97 | 1.52 | 0.51 | 0.56 | 7.4 | β | β | β | β | β | 1.14 | 0.92 | 0.69 | 0.64 | 3.31 | 2.55 | 0.47 | 0.77 |
| Average | 2.11 | 1.67 | 0.38 | 0.23 | 6.8 | β | β | β | β | β | 1.06 | 0.87 | 0.35 | 0.34 | 1.98 | 1.57 | 0.45 | 0.79 | |
| Misc | |||||||||||||||||||
| Galectin | 26 | 0.89 | 0.68 | 0.57 | 0.68 | 13.6 | β | β | β | β | β | 0.42 | 0.36 | 0.76 | 0.84 | 0.88 | 0.72 | 0.53 | 0.76 |
| HIV-1 Protease | 13 | 1.36 | 1.10 | 0.00 | 0.13 | 219.7 | β | β | β | β | β | 0.76 | 0.67 | 0.00 | 0.05 | 1.36 | 1.12 | 0.02 | 0.11 |
| Average | 1.12 | 0.89 | 0.29 | 0.41 | 116.6 | β | β | β | β | β | 0.59 | 0.51 | 0.38 | 0.45 | 1.12 | 0.92 | 0.28 | 0.43 | |
| Overall Average | 1.39 | 1.11 | 0.40 | 0.47 | 26.6 | 1.01 | 0.83 | 0.58 | 0.74 | 18.5 | 0.79 | 0.64 | 0.54 | 0.60 | 1.19 | 0.95 | 0.46 | 0.54 | |
| Method | R2 | Spearman's Ο | MAE | RMSE |
|---|---|---|---|---|
| Rowan FEP/TMD (2ns, AM1-BCC) | 0.868 | 0.909 | 0.373 | 0.465 |
| Rowan FEP/TMD (4ns, Mango/RESP) | 0.928 | 0.938 | 0.291 | 0.338 |
| FEP+ (20ns) | 0.862 | 0.918 | 0.371 | 0.475 |
| OpenFE (5ns) | 0.799 | 0.871 | 0.476 | 0.587 |
This benchmark is from Ross et al. (2023). Rowan FEP/TMD (4ns, Mango/RESP) results are from Rowan Mango 1.0 / RESP (2026-09-30). FEP+ (20ns) results are from Ross et al. (2023). OpenFE (5ns) results are from OpenFE Industry Benchmarks (2024).
Click a point to inspect a molecule